Godavari Drugs Ltd. (GODAVARI): Godavari Drugs Share Price Rises 8.93% to Rs 107.70

Godavari Drugs Share Price moved higher today, with GODAVARI trading at Rs 107.70, up 8.93% from the previous close of Rs 98.87. The company’s market capitalisation stands at Rs 107.91 crore, placing the move in context for investors tracking Godavari Drugs Share Price Today, Godavari Drugs Stock News and broader Stock Market Today action. The latest Univest data confirms a clear share price gain, while it does not establish a company-specific catalyst. For readers following Univest, the event is relevant because the stock moved sharply within the day’s range and is now drawing attention among Stocks Rising Today in the Indian stock market.

For investors scanning Godavari Drugs Share Price Live updates, the move also matters because it comes alongside a small turnover base and a compact market cap, which can amplify price action. In this Godavari Drugs Stock Analysis, the focus is on what the price rise shows, how the valuation reads against the healthcare sector, and what the latest Univest figures imply for follow-up monitoring.

Godavari Drugs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 107.7
Previous Close	Rs 98.87
Today's Move	Rs 8.83 (+8.93%)
Open	Rs 100.18
High	Rs 109.4
Low	Rs 100.1
Turnover	Rs 0.17 crore
Market Capitalisation	Rs 107.91 crore
Market Cap Category	Micro Cap

Godavari Drugs Ltd. (GODAVARI) rose to Rs 107.7 from the previous close of Rs 98.87, a move of Rs 8.83 or 8.93%. The stock opened at Rs 100.18, reached a high of Rs 109.4, recorded a low of Rs 100.1.

Godavari Drugs Share Price Today reflects a firm intraday rise. The stock opened at Rs 100.18, touched a high of Rs 109.40 and a low of Rs 100.10, and last traded at Rs 107.70. That leaves it Rs 8.83 above the previous close, or 8.93% higher, which makes it a notable share price rise in today’s Market News.

The latest Univest data shows that the price action was supported by movement across a relatively tight band rather than a broad trading range. For readers asking Why Is GODAVARI Rising Today, the verified answer is that the stock is rising today, but the data does not establish a company-specific catalyst. In that sense, Godavari Drugs Share Price News is driven by the price event itself and by the market’s attention to an intraday gain in a small-cap healthcare name.

Godavari Drugs Ltd. (GODAVARI) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 107.91 crore
P/E Ratio	25.96x
P/B Ratio	1.37x
ROE	10.64%
ROCE	10.13%
EPS	Rs 3.81
Book Value Per Share	Rs 72.07
Dividend Yield	0%

Godavari Drugs Ltd. (GODAVARI) fundamental metrics show P/E 25.96x, P/B 1.37x, ROE 10.64%, ROCE 10.13%. These figures provide context only and are not a buy or sell signal.

Godavari Drugs Ltd. has a market capitalisation of Rs 107.91 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.96x, P/B at 1.37x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.64% and ROCE of 10.13%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.81, book value per share of Rs 72.07, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.61x, median ROE of 11.79%, median ROCE of 13.66%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	25.96x
Benchmark Median P/E	32.61x
Benchmark Average P/E	48.83x
Benchmark P/E Range	3.32x to 645.91x
Company P/B Ratio	1.37x
Benchmark Median P/B	2.89x
Company ROE	10.64%
Benchmark Median ROE	11.79%
Company ROCE	10.13%
Benchmark Median ROCE	13.66%
Company Market Capitalisation	Rs 107.91 crore
Benchmark Median Market Cap	Rs 730.27 crore

Godavari Drugs Ltd. (GODAVARI) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Godavari Drugs Ltd. (GODAVARI) has a P/E ratio of 25.96x, which is below the benchmark median of 32.61x, a difference of -20.39%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Godavari Drugs Ltd. (GODAVARI) has a ROE of 10.64%, which is below the benchmark median of 11.79%, a difference of -9.75%. Godavari Drugs Ltd. (GODAVARI) has a ROCE of 10.13%, which is below the benchmark median of 13.66%, a difference of -25.84%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,63,791.45	37.77	5.28	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,45,080.59	83.91	13.89	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,90,351.29	85.89	20.87	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,14,832.64	25.09	4.2	19.69	21.39
Cipla Ltd.	CIPLA	1,14,162.52	33.29	3.19	11.83	16

Godavari Drugs Ltd. (GODAVARI) has a P/E ratio of 25.96x compared with the displayed peer median of 37.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.64% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 10.13% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Godavari Drugs Ltd. (GODAVARI) has a market capitalisation of Rs 107.91 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Godavari Drugs

• The stock is rising today by 8.93%, which makes Godavari Drugs Share Price a live market event.
• Its market cap of Rs 107.91 crore keeps it in a small-cap bracket where price movements can stand out.
• Valuation is below the sector median on both P/E and P/B, which keeps Godavari Drugs Fundamental Analysis relevant.
• ROE of 10.64% and ROCE of 10.13% add operating context for Godavari Drugs Stock Analysis.
• The healthcare sector comparison gives investors a benchmark for tracking future Godavari Drugs Share Price Today moves on Univest.

About Godavari Drugs

Godavari Drugs Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of a segment where manufacturing capability, product quality, regulatory standards and pricing discipline often shape investor interest. In Godavari Drugs Company News and Godavari Drugs Latest News searches, readers typically look for both business model clarity and stock-market context.

On the market side, Godavari Drugs Share Price reflects how investors are valuing a small listed pharmaceutical business with a market cap of Rs 107.91 crore, EPS of Rs 3.81, book value of Rs 72.07 and a P/E ratio of 25.96. The company sits in a large healthcare peer universe, which means each move in Godavari Drugs Stock News can become meaningful for traders and long-term readers alike. For users following Univest, the stock page helps connect price action with financial ratios and sector comparison in one place.

Frequently Asked Questions

Why is Godavari Drugs share price rising today?

Ans. Godavari Drugs Share Price is rising today because the stock is up 8.93% and trading at Rs 107.70. The latest Univest data confirms the price event, but it does not establish a company-specific catalyst.

What is Godavari Drugs share price today?

Ans. Godavari Drugs Share Price Today is Rs 107.70. It is trading above the previous close of Rs 98.87, reflecting an intraday gain of 8.93% and drawing attention among healthcare stocks.

How much did Godavari Drugs stock gain today?

Ans. Godavari Drugs stock gained Rs 8.83 per share today. That amounts to an 8.93% rise from the previous close, which makes it one of the notable price movers in the healthcare space.

What is Godavari Drugs market cap?

Ans. Godavari Drugs market capitalisation is Rs 107.91 crore. This places the company in a small-cap category compared with many listed pharmaceuticals peers in the same industry benchmark. The company operates in the Healthcare sector.

What is Godavari Drugs P/E ratio?

Ans. Godavari Drugs has a P/E ratio of 25.96. That is below the same-industry median of 32.61 and well below the average of 48.83, based on latest Univest data.

What is Godavari Drugs P/B ratio?

Ans. Godavari Drugs has a P/B ratio of 1.37. The figure is below the sector median of 2.89 and the average of 4.31, which gives investors a useful valuation reference.

What do Godavari Drugs ROE and ROCE show?

Ans. Godavari Drugs reports ROE of 10.64% and ROCE of 10.13%. These figures suggest moderate return generation and help explain how the stock compares with stronger peers in healthcare.

How does Godavari Drugs compare with healthcare peers?

Its valuation looks lighter, while its scale is much smaller than those companies.

Track Godavari Drugs Share Price on Univest

Use Godavari Drugs Ltd. (GODAVARI) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track Godavari Drugs Share Price on Univest for live price updates, valuation ratios, company financials, market cap, sector comparison and market insights. Univest also helps users follow Godavari Drugs Share Price Today alongside broader Godavari Drugs Stock Performance context. For readers reviewing Godavari Drugs Share Price Update and Godavari Drugs Stock Analysis, the platform keeps the key numbers together in one place.

As the stock remains active in Market News, Univest can help you monitor the next move without losing sight of fundamentals, sector positioning and peer context.